150 related articles for article (PubMed ID: 37879431)
21. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
[TBL] [Abstract][Full Text] [Related]
22. Cardiac amyloidosis and left atrial appendage closure. The CAMYLAAC study.
Amat-Santos IJ; Delgado-Arana JR; Cruz-González I; Gutiérrez H; García-Bolao I; Millán X; Tirado-Conte G; Ruiz-Nodar JM; Mohandes M; Palazuelos J; Torres Saura F; Del Valle R; Valero Picher E; Núñez García JC; Gómez I; Albarrán Rincón R; Arzamendi D; Nombela-Franco L; Korniiko L; Barrero A; Santos-Martínez S; Serrador A; San Román JA
Rev Esp Cardiol (Engl Ed); 2023 Jul; 76(7):503-510. PubMed ID: 35934294
[TBL] [Abstract][Full Text] [Related]
23. Left atrial appendage closure in patients with left atrial appendage thrombus guided by intracardiac echocardiography.
Wang B; Chu H; Wang Z; Fu G; Yu Y; Feng M; Du X
Heart Rhythm; 2024 Jun; 21(6):812-818. PubMed ID: 38272283
[TBL] [Abstract][Full Text] [Related]
24. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
25. Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis.
Zhou Q; Liu X; Gu ZC; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
J Thromb Thrombolysis; 2024 Feb; 57(2):194-203. PubMed ID: 38180590
[TBL] [Abstract][Full Text] [Related]
26. Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion.
Patti G; Sticchi A; Verolino G; Pasceri V; Vizzi V; Brscic E; Casu G; Golino P; Russo V; Rapacciuolo A; Boccuzzi G; Mangieri A; Pagnotta PA; Colombo A;
Am J Cardiol; 2020 Nov; 134():83-90. PubMed ID: 32892987
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience.
Asmarats L; Masson JB; Pagnotta PA; Cook S; Foresti M; Ibrahim R; Sukiennik A; Sabiniewicz R; Maffeo D; Carballo J; Cruz-González I; Grasso C; Pisano F; Senatore G; Tarantini G; Kasongo A; Chiarito M; Puricel S; Messas N; Moreno-Samos JC; O'Hara G; Rodés-Cabau J
JACC Cardiovasc Interv; 2018 Oct; 11(19):1932-1941. PubMed ID: 30249439
[TBL] [Abstract][Full Text] [Related]
28. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Efficacy and Safety of Left Atrial Appendage Closure Procedures.
Zadori A; Kis Z; Toth T; Szigeti M; Temesvari A; Fontos G; Nyolczas N; Andreka P
Int Heart J; 2023 Mar; 64(2):188-195. PubMed ID: 36927928
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy.
Urena M; Rodés-Cabau J; Freixa X; Saw J; Webb JG; Freeman M; Horlick E; Osten M; Chan A; Marquis JF; Champagne J; Ibrahim R
J Am Coll Cardiol; 2013 Jul; 62(2):96-102. PubMed ID: 23665098
[TBL] [Abstract][Full Text] [Related]
31. Stroke prevention of thoracoscopic left atrial appendage clipping in patients with non-valvular atrial fibrillation at high risk of stroke and bleeding: study protocol for a non-randomised controlled clinical trial.
Ye C; Han X; Chen Y; Liu F; Ma H; Yang Y; Liu Y; Hu Q; Yao Q; Xie W; Xu D
BMJ Open; 2022 Oct; 12(10):e063931. PubMed ID: 36307161
[TBL] [Abstract][Full Text] [Related]
32. Left Atrial Appendage Closure in Patients with Atrial Fibrillation and Previous Intracerebral Hemorrhage.
Renou P; Thambo JB; Iriart X; Nicot S; Kabore N; Jalal Z; Olindo S; Debruxelles S; Poli M; Rouanet F; Sibon I
J Stroke Cerebrovasc Dis; 2017 Mar; 26(3):545-551. PubMed ID: 28041899
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of left atrial appendage closure in non-valvular atrial fibrillation in patients over 75 years.
Yu J; Chen H; Post F; Muenzel M; Keil T; Hou CR; Zhao M; Meng Z; Jiang L
Heart Vessels; 2019 Nov; 34(11):1858-1865. PubMed ID: 31144099
[TBL] [Abstract][Full Text] [Related]
34. Should left atrial appendage closure be considered in resistant left atrial appendage thrombus cases? 'Former Foe, New Ally'.
Ates AH; Kivrak A; Karakulak UN; Coteli C; Yorgun H; Sahiner ML; Barıs Kaya E; Aytemir K
Pacing Clin Electrophysiol; 2024 Apr; 47(4):583-590. PubMed ID: 38477017
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of different anticoagulation regimens after left atrial appendage occlusion.
Li W; Gao R; Zhao J; Ren Y; Chen G; Zhu J; Jin K; Zhu L; Ruan Z
Ann Palliat Med; 2022 Jan; 11(1):201-209. PubMed ID: 35144411
[TBL] [Abstract][Full Text] [Related]
36. Impact of sex differences on outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure: A single-center experience.
Zhao M; Post F; Muenzel M; Hou CR; Keil T; Yu J
Int J Med Sci; 2021; 18(9):1990-1998. PubMed ID: 33850469
[TBL] [Abstract][Full Text] [Related]
37. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
Reddy VY; Möbius-Winkler S; Miller MA; Neuzil P; Schuler G; Wiebe J; Sick P; Sievert H
J Am Coll Cardiol; 2013 Jun; 61(25):2551-6. PubMed ID: 23583249
[TBL] [Abstract][Full Text] [Related]
38. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
[TBL] [Abstract][Full Text] [Related]
39. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
[TBL] [Abstract][Full Text] [Related]
40. Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.
Xue X; Jiang L; Duenninger E; Muenzel M; Guan S; Fazakas A; Cheng F; Illnitzky J; Keil T; Yu J
Heart Vessels; 2018 Sep; 33(9):1068-1075. PubMed ID: 29564543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
